Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17634485 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
Condition: Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: nolatrexed dihydrochloride

Indicates status has not been verified in more than two years